Prior studies have shed light on PCK1’s hijacking function and mechanisms in cancer of the colon, hepatocellular carcinoma, breast, kidney, etc. Higher PCK1 activity allows metastatic breast cancer cells to engage in gluconeogenesis, thereby generating glucose and glyceroneogenesis [17]. This evidence concerns the gene PCK1 and hepatocellular carcinoma.